Tom Reijnders – Research output — Amsterdam UMC research portal

Research activity per year

6 Article
1 Comment/Letter to the editor
1 Letter

1 results

Filter

2022

Anti-C5a antibody vilobelimab treatment and the effect on biomarkers of inflammation and coagulation in patients with severe COVID-19: a substudy of the phase 2 PANAMO trial
the Amsterdam UMC COVID-19 Biobank Investigators, 1 Dec 2022, In: Respiratory research. 23, 1, 6 p., 375.
Research output: Contribution to journal › Comment/Letter to the editor › Academic

Open Access

7 Citations (Scopus)